Chemotherapy/radiation therapy plus/minus lonidamine in the treatment of non-small cell lung cancer (limited disease): preliminary results.
Corrado Gallo-Curcio(National Cancer Institute), M. De Gregorio, I Verturo, Riccardo Tonachella, A Antilli, Monica Rinaldi(Institute of Neurobiology and Molecular Medicine), F. Ambesi Impiombato, Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), G.B. Ciottoli, Francesco Tropea
PubMed
December 1, 1988
Cited by 9
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
|The Lancet Oncology|2017|780
Interleukin-12: Biological Properties and Clinical Application
|Clinical Cancer Research|2007|606